What We're Reading: Page 39
Industry reads hand-picked by our editors
Sep 30, 2024
Sep 27, 2024
-
Science
Did a top NIH official manipulate Alzheimer’s and Parkinson’s studies for decades?
-
The New York Times
New R.S.V. Vaccines Had Limited Takers Last Year. Will This Year be Better?
-
Financial Times
Inside the ‘killer cell’ factory
-
The Wall Street Journal
Why Drug Distributors Are Buying Cancer Specialists
Sep 26, 2024
-
Endpoints News
J&J folds cardiovascular and metabolic drug unit
-
Financial Times
How tackling TB could help win the war on superbugs
-
Nature News
Why do obesity drugs seem to treat so many other ailments?